Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma
specificA chronic lymphocytic leukemia/small lymphocytic lymphoma that does not respond to treatment.
8
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 56.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 56.2 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 56.2 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 56.2 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 56.2 |
| 6 | Cleveland Clinic Cancer CenterCleveland, OH | 56.2 |
| 7 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 56.2 |
| 8 | Boston University Cancer CenterBoston, MA | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →